Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Maggi

Showing results (201-210 of 260) with videos related to

Pageof 26
Sort By:
Coronary Artery Disease|December 1, 1993
Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic riskE Maggi, G Finardi, M Poli, et al.
The American Journal of Pathology|December 24, 1997
Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosisC Mavalia, C Scaletti, P Romagnani, et al.
Cancer|July 1, 1993
Serum levels of soluble interleukin-2 receptor in Hodgkin disease. Relationship with clinical stage, tumor burden, and treatment outcomeA Ambrosetti, G Nadali, F Vinante, et al.
European Journal of Immunology|August 14, 2001
Production of IL-4 and leukemia inhibitory factor by T cells of the cumulus oophorus: a favorable microenvironment for pre-implantation embryo developmentM P Piccinni, C Scaletti, C Mavilia, et al.
Presse Medicale (Paris, France : 1983)|July 2, 1994
[Autoantibodies against oxidised low density lipoproteins in patients with coronary disease]E Maggi, G Perani, F Falaschi, et al.
Journal of Clinical Immunology|January 1, 1983
A lymphoproliferative disorder of the large granular lymphocytes with natural killer activityM Ferrarini, S Romagnani, E Montesoro, et al.
Cellular Immunology|October 15, 1985
Different reactivity of activated human B cells to B-cell growth factor and interleukin 2 in the costimulation assay with anti-IgM antibody and in the preactivation assay with Staphylococcus bacteriaF Almerigogna, R Biagiotti, G M Giudizi, et al.
European Journal of Immunology|December 22, 1999
Macrophage-derived chemokine production by activated human T cells in vitro and in vivo: preferential association with the production of type 2 cytokinesG Galli, D Chantry, F Annunziato, et al.
Blood|November 11, 1999
CD30-CD30 ligand interaction in primary cutaneous CD30(+) T-cell lymphomas: A clue to the pathophysiology of clinical regressionM Mori, C Manuelli, N Pimpinelli, et al.
Immunology Letters|June 1, 1996
Role for CD30 in HIV expressionS Romagnani, F Annunziato, R Manetti, et al.
Pageof 26

Showing results (201-210 of 260) with videos related to

Sort By:
Pageof 26
Coronary Artery Disease|December 1, 1993
Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic riskE Maggi, G Finardi, M Poli, et al.
The American Journal of Pathology|December 24, 1997
Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosisC Mavalia, C Scaletti, P Romagnani, et al.
Cancer|July 1, 1993
Serum levels of soluble interleukin-2 receptor in Hodgkin disease. Relationship with clinical stage, tumor burden, and treatment outcomeA Ambrosetti, G Nadali, F Vinante, et al.
European Journal of Immunology|August 14, 2001
Production of IL-4 and leukemia inhibitory factor by T cells of the cumulus oophorus: a favorable microenvironment for pre-implantation embryo developmentM P Piccinni, C Scaletti, C Mavilia, et al.
Presse Medicale (Paris, France : 1983)|July 2, 1994
[Autoantibodies against oxidised low density lipoproteins in patients with coronary disease]E Maggi, G Perani, F Falaschi, et al.
Journal of Clinical Immunology|January 1, 1983
A lymphoproliferative disorder of the large granular lymphocytes with natural killer activityM Ferrarini, S Romagnani, E Montesoro, et al.
Cellular Immunology|October 15, 1985
Different reactivity of activated human B cells to B-cell growth factor and interleukin 2 in the costimulation assay with anti-IgM antibody and in the preactivation assay with Staphylococcus bacteriaF Almerigogna, R Biagiotti, G M Giudizi, et al.
European Journal of Immunology|December 22, 1999
Macrophage-derived chemokine production by activated human T cells in vitro and in vivo: preferential association with the production of type 2 cytokinesG Galli, D Chantry, F Annunziato, et al.
Blood|November 11, 1999
CD30-CD30 ligand interaction in primary cutaneous CD30(+) T-cell lymphomas: A clue to the pathophysiology of clinical regressionM Mori, C Manuelli, N Pimpinelli, et al.
Immunology Letters|June 1, 1996
Role for CD30 in HIV expressionS Romagnani, F Annunziato, R Manetti, et al.
Pageof 26